| Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15–deficient mice MK Kennedy, M Glaccum, SN Brown, EA Butz, JL Viney, M Embers, ... The Journal of experimental medicine 191 (5), 771-780, 2000 | 2012 | 2000 |
| A novel model of inflammatory bowel disease: mice deficient for the multiple drug resistance gene, mdr1a, spontaneously develop colitis CM Panwala, JC Jones, JL Viney The Journal of Immunology 161 (10), 5733-5744, 1998 | 732 | 1998 |
| The anatomical basis of intestinal immunity AMI Mowat, JL Viney Immunological reviews 156 (1), 145-166, 1997 | 709 | 1997 |
| Lymphoid development in mice congenitally lacking T cell receptor αβ-expressing cells KL Philpott, JL Viney, G Kay, S Rastan, EM Gardiner, S Chae, AC Hayday, ... Science 256 (5062), 1448-1452, 1992 | 496 | 1992 |
| Expanding dendritic cells in vivo enhances the induction of oral tolerance JL Viney, AM Mowat, JM O’Malley, E Williamson, NA Fanger The Journal of Immunology 160 (12), 5815-5825, 1998 | 383 | 1998 |
| Interleukin 18 is a primary mediator of the inflammation associated with dextran sulphate sodium induced colitis: blocking interleukin 18 attenuates intestinal damage PV Sivakumar, GM Westrich, S Kanaly, K Garka, TL Born, JMJ Derry, ... Gut 50 (6), 812-820, 2002 | 318 | 2002 |
| Mucosal CD8α+ DC, with a plasmacytoid phenotype, induce differentiation and support function of T cells with regulatory properties J Bilsborough, TC George, A Norment, JL Viney Immunology 108 (4), 481-492, 2003 | 303 | 2003 |
| Rearrangement and diversity of T cell receptor β chain genes in thymocytes: a critical role for the β chain in development CA Mallick, EC Dudley, JL Viney, MJ Owen, AC Hayday Cell 73 (3), 513-519, 1993 | 246 | 1993 |
| Helicobacter-induced inflammatory bowel disease in IL-10- and T cell-deficient mice A Burich, R Hershberg, KIM Waggie, W Zeng, T Brabb, G Westrich, ... American Journal of Physiology-Gastrointestinal and Liver Physiology 281 (3 …, 2001 | 235 | 2001 |
| Modulating dendritic cells to optimize mucosal immunization protocols E Williamson, GM Westrich, JL Viney The Journal of Immunology 163 (7), 3668-3675, 1999 | 208 | 1999 |
| Regulation of mucosal dendritic cell function by receptor activator of NF-κB (RANK)/RANK ligand interactions: impact on tolerance induction E Williamson, JM Bilsborough, JL Viney The Journal of Immunology 169 (7), 3606-3612, 2002 | 194 | 2002 |
| Immunoglobulin synthesis and generalized autoimmunity in mice congenitally deficient in αβ (+) T cells L Wen, SJ Roberts, JL Viney, FS Wong, C Mallick, RC Findly, Q Peng, ... Nature 369 (6482), 654-658, 1994 | 186 | 1994 |
| BTNL2, a butyrophilin/B7-like molecule, is a negative costimulatory molecule modulated in intestinal inflammation HA Arnett, SS Escobar, E Gonzalez-Suarez, AL Budelsky, LA Steffen, ... The Journal of Immunology 178 (3), 1523-1533, 2007 | 181 | 2007 |
| Gastrointestinal dendritic cells play a role in immunity, tolerance, and disease J Bilsborough, JL Viney Gastroenterology 127 (1), 300-309, 2004 | 180 | 2004 |
| Helicobacter bilis infection accelerates and H. hepaticus infection delays the development of colitis in multiple drug resistance-deficient (mdr1a−/−) mice L Maggio-Price, D Shows, K Waggie, A Burich, W Zeng, S Escobar, ... The American journal of pathology 160 (2), 739-751, 2002 | 178 | 2002 |
| Immune modulation by butyrophilins HA Arnett, JL Viney Nature Reviews Immunology 14 (8), 559-569, 2014 | 171 | 2014 |
| Mucosal addressin cell adhesion molecule-1: a structural and functional analysis demarcates the integrin binding motif. JL Viney, S Jones, HH Chiu, B Lagrimas, ME Renz, LG Presta, D Jackson, ... Journal of immunology (Baltimore, Md.: 1950) 157 (6), 2488-2497, 1996 | 144 | 1996 |
| Defining the roles of perforin, Fas/FasL, and tumour necrosis factor α in T cell induced mucosal damage in the mouse intestine M Merger, JL Viney, R Borojevic, D Steele-Norwood, P Zhou, DA Clark, ... Gut 51 (2), 155-163, 2002 | 136 | 2002 |
| Methods of inducing inflammatory bowel disease in mice B Bang, LM Lichtenberger Current Protocols in Pharmacology 72 (1), 5.58. 1-5.58. 42, 2016 | 133 | 2016 |
| High antigen dose and activated dendritic cells enable Th cells to escape regulatory T cell‐mediated suppression in vitro TC George, J Bilsborough, JL Viney, AM Norment European journal of immunology 33 (2), 502-511, 2003 | 125 | 2003 |